Project Grant HT94252310458
Award Date 7/1/23
Completion Date 6/30/26
Dollars Obligated $1.4M
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Hamden, CT 06511, USA
Similar Awards
- The Defense Health Agency awarded a $1,296,293 project grant to Yale University to conduct preclinical testing of methylone as a therapeutic for opioid use disorder. The grant, provided under the Military Medical Research and Development program (CFDA 12.420), will support this investigative research project over a 2-year period from July 15, 2024 to July 14, 2026. The goal of this project is to advance the development of novel treatments for opioid addiction by evaluating the potential...
- The U.S. Defense Health Agency awarded a $1,675,000.00 Project Grant to Yale University to support the "DRUG DISCOVERY FOR DYSTONIA AND FRONTOTEMPORAL DEGENERATION" research project. This award is funded through the Military Medical Research and Development program (CFDA 12.420), which supports advanced biomedical research to transform healthcare for military service members, veterans, and the general public. The project period runs from August 15, 2025 to August 14, 2029 and will...
- The U.S. Department of Defense, through its Military Medical Research and Development program (CFDA 12.420), awarded a $460,279 Project Grant to Yale University on February 15, 2025. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research project, titled "LOSS OF PROTEOSTASIS AND VASCULAR AMYLOIDOSIS," focuses on investigating medical solutions for the battlefield and developing...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $4,899,065.00 to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. to conduct a randomized, double-blind, active-controlled clinical trial evaluating the safety, efficacy, and durability of MDMA-assisted therapy for military service members with post-traumatic stress disorder (PTSD). The award period runs from September 1,...
- The U.S. Defense Health Agency awarded a $1,213,276 Project Grant to Yale University under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, effective September 1, 2023 through August 31, 2026, will fund research on the role of vascular mimicry in the outgrowth of dormant melanoma micrometastases. The goal of this research is to transform health care for Service Members and the American public through innovative and impactful medical research on solutions...
- The U.S. Department of Defense's Defense Health Agency awarded a $1,235,447 Project Grant to Yale University on July 1, 2023. This 3-year grant, funded under the Military Medical Research and Development program (CFDA 12.420), will support research targeting the chromatin regulator WDR5 to treat breast cancer metastasis. The project aims to transform health care for service members and the general public through innovative and impactful biomedical research investigating medical solutions for the...
- The Yale University was awarded a $1,244,745 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 2021 to June 2025 to overcome resistance to EGFR inhibitors in advanced head and neck cancers. The Military Medical Research and Development program supports biomedical research to transform military and public health care through innovative solutions. This award will further...
- The Yale University was awarded a $753,749 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from March 2022 through March 2025 to target replication stress in triple-negative breast cancer. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care...
- This $5,620,000 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will fund MDMA-assisted massed exposure therapy for the treatment of post-traumatic stress disorder (PTSD) at Emory University in Atlanta, Georgia. The award will support advanced biomedical research to develop innovative medical solutions that address critical health challenges relevant to military personnel and civilian populations. The project has a...
- The Yale University was awarded a $2.6 million Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The four-year award will support research exploring protein quality control dysfunction in dystonia from August 2021 through August 2025. Through this funding, Yale University researchers will investigate medical solutions for neurological disorders like dystonia, with the aim of transforming healthcare for service members and...